conjunto de presentaciones
TRANSCRIPT
Used drug Frequency of reaction
Tested drug Frequency of reaction PATCH TEST PRICK TEST INTRADERMOREACTION
Risperidone No Risperidone No Negative Negative -----------
Clonazepam No Clonazepam No Negative
Negative
-----------
Carbamazepine Yes ----------- ----------- ----------- ----------- -----------
Haloperidol Yes ----------- ----------- ----------- ----------- -----------
Levomepromazine NO ----------- ----------- ----------- ----------- -----------
Biperidene NO Biperidene No Positive Negative Negative
-----------
-----------
Valproate
No Negative Negative -----------
-----------
-----------
Paroxetine
No Negative -----------
-----------
Patch Test
Patch Test Negativo
Prick Test: Biperidene Negativo
Patch Test: Biperidene Positivo.
BIBLIOGRAFIA
1) Aldama A, Correa J, Mendoza G, Rivelli V. Eritrodermia: Informe de 35 casos. Dermatología Rev Mex 1998; 42 (6) 239‐243. 2) Fernández‐Chico N, Bielsa Marsol I. Síndrome de hipersensibilidad a fármacos.Piel 2003; 18 (5): 252‐258. 3) Galdeano, F MD; Parra, V MD; Carena, J A MD; Erytrhoderma in 3160‐Patients at Clinical Department. Rev Argent Dermatol 2007; 88: 90‐94. 4) Jaime R, Lagodín C, Dahbar M, Allevato M, Cabrera H, Devés A .Eritrodermias.Estudio retrospectivo clínico‐patológico de 45 casos. Med Cutan Iber Lat Am. 2005; 33 (4): 159‐16 5) Roujeau JC, Stern RS. Severe adverse cutaneous reactions to drugs. N Engl JMed 1994; 331: 1272‐1285 6) Rzany B, Correia O, Kelly J, Naldi L, Auquier A, Stern R. For the studygroup of the international case‐control study on severe cutaneous adverse reactions risk of Stevens‐Johnson syndrome and toxic epidermal necrolysis duringfirst weeks of antiepileptic therapy: A case‐control study. Lancet 1999; 353:2190‐2194